Elevance Health, Inc.
ELV- Exchange
- NYSE
- Industry
- Hospital & Medical Service Plans
- SEC CIK
- 0001156039
In the last 90 days, Elevance Health, Inc. insiders filed 2 open-market purchases and 0 sales; 1,614 institutions reported holding it in 13F filings for Q2 2026, worth $78.6B in total; superinvestors Harris Associates (Oakmark) and Baupost Group hold it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Elevance Health, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 2 filings
- 2 insiders, $1.37M in total
- Open-market sells
- 0 filings
- Insiders trading
- 2
- Net value
- +$1.37M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Elevance Health, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Wessling Erin M | EVP & Chief Legal Officer | 7,230 | Sep 4, 2026 | 2 |
| Craig Ryan R | EVP & Chief HR Officer | 6,530 | Sep 4, 2026 | 3 |
| Peru Ramiro G | Director | 10,908 | Jul 17, 2026 | 2 |
| Boudreaux Gail | President and CEO | 171,976 | Jul 17, 2026 | 2 |
| Penczek Ronald W | CAO & Controller | 3,740 | Jun 15, 2026 | 3 |
| Dixon Robert L JR | Director | 10,734 | Jun 12, 2026 | 2 |
| Hay Lewis III | Director | 12,070 | May 15, 2026 | 1 |
| Collis Steven H | Director | 4,202 | May 15, 2026 | 2 |
| Strable-Soethout Deanna D | Director | 2,209 | May 15, 2026 | 1 |
| Schneider Ryan M. | Director | 7,163 | May 15, 2026 | 1 |
| Schulman Amy W | Director | 781 | May 15, 2026 | 3 |
| DeVore Susan D. | Director | 4,065 | May 15, 2026 | 1 |
| Neri Antonio F | Director | 5,488 | May 15, 2026 | 1 |
| Jallal Bahija | Director | 5,351 | May 15, 2026 | 1 |
| Kendrick Charles Morgan JR | EVP & President, Commercial | 11,791 | Mar 9, 2026 | 2 |
| Haytaian Peter D | EVP & Pres Carelon & CarelonRx | 27,222 | Mar 4, 2026 | 1 |
| Lavu Ratnakar | EVP & Chief Digital Info Ofr | 16,149 | Mar 4, 2026 | 1 |
| Norwood Felicia F | EVP &Chief Health Benefits Ofr | 38,838 | Mar 4, 2026 | 1 |
| Kaye Mark | EVP & CFO | 32,037 | Mar 4, 2026 | 2 |
| Clark R Kerry | Director | 9,640 | May 16, 2025 | 0 |
| Todt Blair Williams | EVP, CLO & CAO | 15,631 | Jan 7, 2025 | 0 |
| Tallett Elizabeth E | Director | 10,291 | May 17, 2024 | 0 |
| McCarthy Gloria M | EVP & Chief Administrative Off | 51,435 | Mar 27, 2023 | 0 |
| Gallina John E | EVP & Chief Financial Officer | 63,725 | Mar 3, 2023 | 0 |
| Stark Leah | EVP & CHRO | 12,403 | Jan 4, 2022 | 0 |
| Alter Jeffrey D. | EVP, IngenioRx & Anthem Health | 5,107 | Oct 4, 2021 | 0 |
| Patel Prakash R | EVP & President, DBG | 17,230 | Sep 8, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 (view filing)3:04 PM ET | Jul 17 | Same day | Peru Ramiro GDirector | PPurchase | +1.00K | $366.05 | +$366.1K | +10.1%10.9K after | |
| Jul 17, 2026 (view filing)1:50 PM ET | Jul 17 | Same day | Boudreaux GailPresident and CEO | PPurchase | +2.73K | $367.79 | +$1.00M | +1.6%172.0K after | 2 lots |
| Jun 15, 2026 (view filing) | Jun 12 | 3 days | Penczek Ronald WCAO & Controller | SSale | −369 | $403.16 | −$148.8K | −9.0%3.74K after | |
| Jun 12, 2026 (view filing) | Jun 11 | 1 day | Dixon Robert L JRDirector | SSale | −151 | $401.77 | −$60.7K | −1.4%10.7K after | |
| May 20, 2026 (view filing) | May 19 | 1 day | Penczek Ronald WCAO & Controller | SSale | −1.53K | $403.13 | −$617.2K | −27.1%4.11K after | |
| Mar 23, 2026 (view filing) | Mar 12 | 11 daysLate | Schulman Amy WDirector | SSale | −26 | $287.50 | −$7.47K | −10.7%218 after | |
| Mar 9, 2026 (view filing) | Mar 6 | 3 days | Kendrick Charles Morgan JREVP & President, Commercial | SSale | −3.20K | $284.92 | −$910.6K | −21.3%11.8K after | |
| Mar 6, 2026 (view filing) | Mar 5 | 1 day | Collis Steven HDirector | PPurchase | +3.00K | $289.84 | +$869.5K | +469.5%3.64K after | |
| Aug 21, 2025 (view filing) | Aug 19 | 2 days | DeVore Susan D.Director | PPurchase | +1.20K | $312.15 | +$374.6K | +52.1%3.50K after | |
| Jul 18, 2025 (view filing) | Jul 18 | Same day | Boudreaux GailPresident and CEO | PPurchase | +8.50K | $286.94 | +$2.44M | +6.0%151.0K after | 3 lots |
| Apr 25, 2025 (view filing) | Apr 24 | 1 day | Kaye MarkEVP & CFO | SSale | −4.59K | $424.82 | −$1.95M | −19.5%19.0K after | |
| Mar 11, 2025 (view filing) | Mar 10 | 1 day | Penczek Ronald WCAO & Controller | SSale | −443 | $415.13 | −$183.9K | −19.3%1.85K after | |
| Mar 5, 2025 (view filing) | Mar 5 | Same day | Kendrick Charles Morgan JREVP & President, Commercial | SSale | −3.50K | $396.30 | −$1.39M | −25.7%10.1K after | |
| Oct 18, 2024 (view filing) | Oct 18 | Same day | Kendrick Charles Morgan JREVP & President, Commercial | SSale | −7.42K | $432.14 | −$3.21M | −46.8%8.42K after | |
| Aug 6, 2024 (view filing) | Aug 5 | 1 day | Peru Ramiro GDirector | SSale | −753 | $531.52 | −$400.2K | −7.9%8.74K after | 10b5-1 |
| Jul 23, 2024 (view filing) | Jul 22 | 1 day | Boudreaux GailPresident and CEO | SSale | −34.0K | $500.98 | −$17.0M | −21.2%126.7K after | 6 lots10b5-1 |
| Jul 22, 2024 (view filing) | Jul 19 | 3 days | Dixon Robert L JRDirector | SSale | −305 | $506.76 | −$154.6K | −3.0%9.72K after | |
| Apr 25, 2024 (view filing) | Apr 23-24 | 2 days | Norwood Felicia FEVP & President,Gov Health Ben | SSale | −20.3K | $533.34 | −$10.8M | −42.7%27.3K after | 4 lots |
| Mar 12, 2024 (view filing) | Mar 8 | 4 days | Kendrick Charles Morgan JREVP & President, Commercial | SSale | −2.43K | $500.46 | −$1.22M | −13.3%15.8K after | |
| Mar 8, 2024 (view filing) | Mar 6 | 2 days | Penczek Ronald WCAO & Controller | SSale | −916 | $504.58 | −$462.2K | −34.2%1.76K after | |
| Mar 5, 2024 (view filing) | Mar 4 | 1 day | Haytaian Peter DEVP & Pres Carelon & CarelonRx | SSale | −21.1K | $500.18 | −$10.6M | −52.8%18.9K after | 3 lots10b5-1 |
| Feb 9, 2024 (view filing) | Feb 7 | 2 days | Peru Ramiro GDirector | SSale | −753 | $500.00 | −$376.5K | −7.6%9.11K after | 10b5-1 |
| Dec 15, 2023 (view filing) | Dec 14 | 1 day | Todt Blair WilliamsEVP, CLO & CAO | SSale | −5.49K | $484.02 | −$2.66M | −30.5%12.5K after | |
| Dec 1, 2023 (view filing) | Nov 30 | 1 day | Penczek Ronald WCAO & Controller | SSale | −1.05K | $475.17 | −$501.3K | −37.1%1.79K after | |
| Oct 26, 2023 (view filing) | Oct 24 | 2 days | Penczek Ronald WCAO & Controller | SSale | −64 | $454.35 | −$29.1K | −2.2%2.84K after | |
| Jul 21, 2023 (view filing) | Jul 21 | Same day | Dixon Robert L JRDirector | SSale | −310 | $476.71 | −$147.8K | −3.1%9.64K after | |
| Mar 27, 2023 (view filing) | Mar 24 | 3 days | McCarthy Gloria MEVP & Chief Administrative Off | SSale | −15.1K | $444.76 | −$6.71M | −22.7%51.4K after | 6 lots10b5-1 |
| Mar 13, 2023 (view filing) | Mar 9 | 4 days | Kendrick Charles Morgan JREVP & President, Commercial | SSale | −2.31K | $462.22 | −$1.07M | −13.1%15.3K after | |
| Jun 13, 2022 (view filing) | Jun 9 | 4 days | Kendrick Charles Morgan JREVP & President, Commercial | SSale | −6.33K | $488.60 | −$3.09M | −30.3%14.5K after | 5 lots |
| Jun 7, 2022 (view filing) | Jun 6 | 1 day | Dixon Robert L JRDirector | SSale | −420 | $497.14 | −$208.8K | −4.2%9.49K after | |
| May 20, 2022 (view filing) | May 19 | 1 day | Peru Ramiro GDirector | SSale | −990 | $468.88 | −$464.2K | −9.5%9.40K after | |
| Mar 14, 2022 (view filing) | Mar 10 | 4 days | Haytaian Peter DEVP & Pres., DBG & IngenioRx | SSale | −17.7K | $460.71 | −$8.16M | −59.3%12.2K after | 6 lots |
| Mar 3, 2022 (view filing) | Mar 3 | Same day | Penczek Ronald WCAO & Controller | SSale | −2.42K | $463.68 | −$1.12M | −56.0%1.90K after | |
| Feb 8, 2022 (view filing) | Feb 7 | 1 day | Penczek Ronald WCAO & Controller | SSale | −2.76K | $453.48 | −$1.25M | −57.9%2.01K after | |
| Oct 29, 2021 (view filing) | Oct 28 | 1 day | Penczek Ronald WSVP, Chief Accounting Officer | SSale | −1.15K | $436.00 | −$501.4K | −36.4%2.01K after | |
| Jul 26, 2021 (view filing) | Jul 23 | 3 days | Schneider Ryan M.Director | PPurchase | +1.30K | $384.36 | +$499.7K | +38.1%4.71K after |